| Literature DB >> 34724576 |
Pedja Cuk1,2, Mie Dilling Kjær3, Christian Backer Mogensen4, Michael Festersen Nielsen5,4, Andreas Kristian Pedersen4, Mark Bremholm Ellebæk3.
Abstract
BACKGROUND: Robot-assisted surgery is increasingly adopted in colorectal surgery. However, evidence for the implementation of robot-assisted surgery for colon cancer is sparse. This study aims to evaluate the short-term outcomes of robot-assisted colon surgery (RCS) for cancer compared to laparoscopic colon surgery (LCS).Entities:
Keywords: Colon cancer; Laparoscopy; Minimally invasive surgery; Robot-assisted surgery
Mesh:
Year: 2021 PMID: 34724576 PMCID: PMC8741661 DOI: 10.1007/s00464-021-08782-7
Source DB: PubMed Journal: Surg Endosc ISSN: 0930-2794 Impact factor: 4.584
Fig. 1PRISMA flowchart of study selection process
Study characteristics
| Author country Y.O. publ. study period | N.O. patients RCS/LCS | Anastomosis technique, RCS/LCS (EC/IC/NA), | Age (years), mean ± SD, RCS/LCS | BMI, mean (kg/m2) RCS/LCS | Study type | Tumor location |
|---|---|---|---|---|---|---|
| Bertani, Italy, 2011, 2009–2010 [ | 34/30 | IC and EC | 62.5 ± 8.4/62.0 ± 10.2 | 26.1 ± 3.71/24.6 ± 3.54 | Prospective | Right and left colon |
| Park, Korea, 2012, 2009–2011 [ | 35/35 | RCS − EC: 5 (14), RCS − IC: 30 (86), LCS − EC: 28 (80), LCS − IC: 7 (20) | 62.8 ± 10.5/66.5 ± 11.4 | 24.4 ± 2.5/23.8 ± 2.7 | RCT | Right colon |
| Lim, Korea, 2012, 2006–2008 [ | 34/146 | Only EC | 59.6 ± 8.4/59.7 ± 11.5 | 24.8 ± 2.1/23.8 ± 3.8 | Retrospective | Left colon |
| Helvind, Denmark, 2013, 2009–2012 [ | 101/162 | Only EC | 72.2 (39–93)/75.3 (47–96) | 24.6 (16.8–36.0)/24.9 (15.2–45.7) | Retrospective | Right and left colon |
| Morpurgo, Italy, 2013, 2008–2012 [ | 48/48 | RCS − IC: 48 (50), LCS − EC: 48 (50) | 68.8 ± 8/74 ± 11 | 25 ± 3.5/28 ± 4 | Retrospective | Right colon |
| de'Angelis, France, 2015, 2010–2014 [ | 22/22 | Only EC | 72.18 ± 10.79/71 ± 10.14 | 24.12 ± 2.64/24.28 ± 2.7 | Prospective | Transverse colon |
| Guerrieri, Italy, 2015, 2013–2014 [ | 24/23 | RCS − EC: 5 (21), RCS − IC: 19 (79), LCS − EC: 11 (48), LCS − IC: 12 (52) | 69.5 (57–80)/65.5 (57–75) | 26 (23–28)/26.5 (23–29) | Retrospective | Right and left colon |
| Kang, Korea, 2016, 2007–2011 [ | 20/43 | Only EC | 66.0 ± 9.6/65.7 ± 13.2 | 23.5 ± 2.4/23.0 ± 3.0 | Retrospective | Right colon |
| Jung, Korea, 2016, 2007–2013 [ | 51/161 | NR | 60.2 ± 9.5/60.3 ± 11.3 | 23.5 ± 3.0/23.2 ± 2.8 | Retrospective | Right and left colon |
| de'Angelis, France, 2016, 2012–2015 [ | 30/50 | Only EC | 71 ± 8.5/71.1 ± 12.92 | 26.43 ± 3.21/25.26 ± 4.19 | Prospective | Right colon |
| Cardinali, Italy, 2016, 2013–2015 [ | 30/60 | RCS − IC: 30 (33), LCS − EC: 60 (67) | 68.67 ± 12.93/70.78 ± 9.56 | 25.44 ± 4.30/26.36 ± 3.17 | Retrospective | Right colon |
| Widmar, USA, 2017, 2012–2014 [ | 119/163 | NR | 68 (58–77)/64 (54–75) | 28 (24–32)/29 (25–32) | Retrospective | Right colon |
| Kim, Korea, 2018, 2012–2017 [ | 20/51 | Only EC | 58 ± 10/56 ± 13 | 25.5 ± 3.8/24 ± 3.0 | Retrospective | Left colon |
| Scotton, Italy, 2018, 1998–2017 [ | 206/160 | RCS − IC: 206 (56), LCS − EC: 160 (44) | 70.1 ± 11.7/70.3 ± 12.7 | 26.0 ± 3.7/25.6 ± 5.9 | Retrospective | Right colon |
| Ngu, Singapore, 2018, 2015–2017 [ | 16/16 | Only IC | 68.6 ± 10.9/69.6 ± 9.6 | 23.7 ± 3.8/24.7 ± 4.2 | Retrospective | Right colon |
| Spinoglio, Italy, 2018, 2005–2013 [ | 100/100 | Only IC | 71.2 ± 10.2/71.2 ± 10.6 | 25.1 ± 4/25.8 ± 4.4 | Retrospective | Right colon |
| Mégevand, Italy, 2018, 2010–2015 [ | 50/50 | RCS − IC: 49 (98), RCS − EC: 1 (2), LCS − IC: 18 (36), LCS − EC: 32 (64) | 70.3/69.6 | 26.2/25.25 | Retrospective | Right colon |
| Fransgaard, Denmark, 2018, 2010–2015 [ | 511/8104 | NR | NE | NE | Retrospective | Right and left colon/rectum |
| Haskins, USA, 2018, 2012–2014 [ | 89/2405 | NR | 68.9 ± 11.8/68.3 ± 12.2 | 29.3 ± 6.3/28.5 ± 6.3 | Retrospective | Right colon |
| Polat, Netherlands, 2019, 2014–2017 [ | 129/138 | RCS − IC: 129 (48), LCS − IC + EC: 138 (52) depending on the surgeon's choice | NE | NE | Retrospective | Right and left colon/rectum |
| Merola, Italy, 2019, 2012–2017 [ | 94/94 | RCS − IC: 94 (50), LCS − IC: 94 (50) | 69.41 ± 10.31/72.09 ± 9.54 | 26.94 ± 4.91/27.97 ± 5.73 | Retrospective | Right colon |
| Yozgatli, Turkey, 2019, 2015–2017 [ | 35/61 | RCS− IC: 35 (36), LCS − IC and EC 61 (54) based on surgeon's choice | 65 ± 13/65 ± 13 | 29 ± 5/27 ± 5 | Retrospective | Right colon |
| Ozben, Turkey, 2020, 2011–2018 [ | 38/80 | RCS − IC: 33 (86.8), RCS − EC: 4 (10.5), RCS − NA: 1 (2.6), LCS − IC: 16 (20.0), LCS − EC: 60 (75), LCS − NA: 4 (5.0) | 62.3 ± 15.7/64.1 ± 15.5 | 25.3 ± 4.5/26.7 ± 5.7 | Retrospective | Transverse colon |
| Ceccarelli, Italy, 2020, 2014–2019 [ | 26/29 | Only IC | 69.1 ± 9.4/75.0 ± 11.7 | 24.4 ± 3.8/24.2 ± 2.8 | Retrospective | Right colon |
| Total N.O. patients | 1862 (13%)/12,231 (87%) |
Y.O. publ year of publication, N.O. number of, RCS robot-assisted colon surgery, LCS laparoscopic colon surgery, EC extracorporeal, IC intracorporeal, NA no anastomosis, RCT randomized controlled trial, SD standard deviation, NR not reported, NE not estimable
Meta-analysis of patient characteristics in the included studies
| Outcome | N.O. Studies | RCS | LCS | OR/MD 95% CI | ||
|---|---|---|---|---|---|---|
| Age (SD) | 17 | 66.87 (10.31) | 67.69 (10.81) | − 0.67 [− 2.46, 1.11] | 80.85 | 0.46 |
| BMI (SD) | 17 | 25.54 (3.58) | 25.49 (4.03) | 0.02 [− 0.47, 0.51] | 63.54 | 0.95 |
| Male gender (%) | 19 | 918 (56.9) | 5960 (50.0) | 1.31 [1.16, 1.47] | 59.07 | 0.00 |
| Previous abdominal surgery (%) | 13 | 246 (30.8) | 344 (32.9) | 0.76 [0.62, 0.95] | 0.00 | 0.01 |
| ASA ≥ 3 (%) | 16 | 286 (30.2) | 1629 (45.3) | 0.94 [0.77, 1.14] | 26.60 | 0.53 |
| T-stage ≥ 3 (%) | 18 | 831 (54.9) | 6736 (71.7) | 0.90 [0.79, 1.04] | 0.00 | 0.14 |
N.O. number of, RCS robot-assisted colon surgery, LCS laparoscopic colon surgery, OR odds ratio, MD mean difference, CI = confidence interval, I2 heterogeneity
Fig. 2Forest plot of anastomotic leakage
Fig. 3Forest plot of conversion rate to open surgery
Fig. 4Forest plot of length of hospital stay
GRADE quality of evidence assessment of most important clinical outcomes in robot-assisted to laparoscopic colon cancer surgery
| Participants (studies) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk of bias | Inconsistency | Indirectness | Imprecision | Publication bias | Overall certainty of evidence | Study event rates (%) | Relative effect (95% CI) | Anticipated absolute effects | |||
| With laparoscopic surgery | With robot-assisted | Risk with laparoscopic surgery | Risk difference with robot-assisted | ||||||||
| Anastomotic leak | |||||||||||
| 2280 (15 Observational studies) | Seriousa | Not serious | Not serious | Seriousb | None | ⨁◯◯◯ VERY LOW | 41/1310 (3.1%) | 16/970 (1.6%) | OR 0.54 (0.32 to 0.94) | 31 Per 1000 | 14 Fewer per 1000 (from 21 to 2 fewer) |
| Overall complication rate | |||||||||||
| 13,799 (20 Observational studies) | Very seriousc | Not serious | Not serious | Not serious | None | ⨁◯◯◯ VERY LOW | 2051/12,059 (17.0%) | 303/1740 (17.4%) | OR 0.85 (0.73 to 1.00) | 170 Per 1000 | 22 Fewer per 1000 (from 40 to 0 fewer) |
| Conversion | |||||||||||
| 10,906 (17 Observational studies) | Seriousa | Not serious | Not serious | Not serious | None | ⨁◯◯◯ VERY LOW | 1380/9352 (14.8%) | 52/1554 (3.3%) | OR 0.31 (0.23 to 0.41) | 148 Per 1000 | 97 Fewer per 1000 (from 109 to 81 fewer) |
| Intraoperative blood loss | |||||||||||
| 635 (8 Observational studies) | Seriousa | Seriousd | Not serious | Not serious | Publication bias strongly suspected e | ⨁◯◯◯ VERY LOW | 417 | 218 | – | The mean intraoperative blood loss was 83.8 mL | MD 0.33 lower (16.54 lower to 15.88 higher) |
| Length of hospital stay | |||||||||||
| 4635 (17 Observational studies) | Very seriousc | Very seriousf | Not serious | Not serious | None | ⨁◯◯◯ VERY LOW | 3654 | 981 | - | The mean length of hospital stay was 7.09 days | MD 0.58 lower (1.37 lower to 0.21 higher) |
| Clavien–Dindo grade IV–V | |||||||||||
| 1041 (8 Observational studies) | Seriousa | Not serious | Not serious | Very seriousb | None | ⨁◯◯◯ VERY LOW | 27/578 (4.7%) | 15/463 (3.2%) | OR 0.73 (0.38 to 1.37) | 47 Per 1000 | 12 Fewer per 1000 (from 28 fewer to 16 more) |
| Mortality | |||||||||||
| 4754 (15 Observational studies) | Seriousa | Not serious | Not serious | Very seriousb | None | ⨁◯◯◯ VERY LOW | 18/3657 (0.5%) | 3/1097 (0.3%) | OR 0.76 (0.35 to 1.67) | 5 Per 1000 | 1 Fewer per 1000 (from 3 fewer to 3 more) |
CI confidence interval, OR odds ratio, MD mean difference
aRisk of bias assessment on outcome level downgraded by one level due to serious limitations
bTotal number of events < 400 (small optimal information size)
cRisk of bias assessment on outcome level downgraded by two levels due to very serious limitations
dSubstantial heterogeneity
eFunnel plot suggest heterogeneity
fConsiderable heterogeneity